Mylan to combine with Pfizer's off-patent drugs unit
Pfizer will separate its off-patent drugs business and merge it with Mylan, the two companies have confirmed, bringing blockbuster treatments Viagra, EpiPen and Lipitor under …
Business
•
29 Jul 19